Verve Therapeutics, Inc.

NASDAQ:VERV

6.42 (USD) • At close March 12, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -198.709-200.068-157.387-120.314-45.704-19.297
Depreciation & Amortization 05.4552.8041.5351.3280.106
Deferred Income Tax 0001.5080.38-0.072
Stock Based Compensation 43.25535.11622.4777.0720.850.446
Change In Working Capital -2.26117.7038.38-2.9122.6422.661
Accounts Receivables 2.6380-1.012000
Inventory 001.012000
Accounts Payables -1.833.91-5.2166.829-1.8981.735
Other Working Capital -3.06913.79313.596-9.7414.540.926
Other Non Cash Items 0.023-7.7551.39435.2315.2398.714
Operating Cash Flow -157.692-149.549-122.332-77.88-35.265-7.442
Investing Activities:
Investments In Property Plant And Equipment 0-9.283-13.232-4.359-3.424-1.857
Acquisitions Net 00142.723234.73947.70310.901
Purchases Of Investments 0-517.14-479.401-371.494-98.484-22.001
Sales Maturities Of Investments 0554.113336.678136.75550.78111.1
Other Investing Activites 74.8760-142.723-234.739-47.703-10.901
Investing Cash Flow 74.87627.69-155.955-239.098-51.127-12.758
Financing Activities:
Debt Repayment 000000
Common Stock Issued 46.734210.456326.495285.21492.62718.04
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 2.4622.1212.46191.87592.62717.954
Financing Cash Flow 49.196212.577328.956377.08992.62717.954
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -33.6290.71850.66960.1116.235-2.246
Cash At End Of Period 177.334210.954120.23669.5679.4563.221